Additionally, the decrease in ARL4C expression leads to the impairment of cancer cell proliferation and migration in vitro and in vivo, as well as a reduction in expression of PI3K Catalytic subunit Delta (PI3KCD) mRNA and activity of Akt (Harada et al., 2019). Here, ARL4C is linked to cancer.